Mutual Of America Capital Management LLC Regenxbio Inc. Transaction History

Mutual Of America Capital Management LLC

$9.01 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$22.29 - $35.04 $24,697 - $38,824	1,108 Added 17.38%	7,483 $198,000
Q2 2022 Aug 10, 2022	BUY	$19.35 - $35.04 $18,421 - $33,358	952 Added 17.55%	6,375 $157,000
Q1 2022 May 02, 2022	BUY	$24.62 - $34.31 $6,918 - $9,641	281 Added 5.46%	5,423 $180,000
Q4 2021 Feb 03, 2022	BUY	$30.19 - $40.28 $4,317 - $5,760	143 Added 2.86%	5,142 $168,000
Q3 2021 Nov 10, 2021	BUY	$29.09 - $45.68 $1,250 - $1,964	43 Added 0.87%	4,999 $210,000
Q2 2021 Aug 06, 2021	BUY	$32.46 - $40.48 $9,802 - $12,224	302 Added 6.49%	4,956 $193,000
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $30,148 - $44,805	897 Added 23.88%	4,654 $159,000
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $4,322 - $8,044	163 Added 4.54%	3,757 $170,000
Q3 2020 Nov 13, 2020	BUY	$27.01 - $40.26 $55,208 - $82,291	2,044 Added 131.87%	3,594 $99,000
Q2 2020 Aug 06, 2020	BUY	$27.75 - $43.44 $4,967 - $7,775	179 Added 13.06%	1,550 $57,000
Q1 2020 May 11, 2020	BUY	$21.5 - $54.2 $6,321 - $15,934	294 Added 27.3%	1,371 $44,000
Q4 2019 Feb 11, 2020	SELL	$34.54 - $44.87 $2,659 - $3,454	-77 Reduced 6.67%	1,077 $44,000
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $1,337 - $2,136	42 Added 3.78%	1,154 $41,000
Q2 2019 Aug 12, 2019	BUY	$42.0 - $59.29 $9,702 - $13,695	231 Added 26.22%	1,112 $57,000
Q1 2019 May 13, 2019	BUY	$40.82 - $62.45 $6,000 - $9,180	147 Added 20.03%	881 $50,000
Q4 2018 Feb 12, 2019	BUY	$39.11 - $75.15 $6,844 - $13,151	175 Added 31.31%	734 $31,000
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $29,900 - $37,789	460 Added 464.65%	559 $42,000
Q2 2018 Aug 09, 2018	BUY	$27.2 - $74.35 $2,692 - $7,360	99 New	99 $7,000

Others Institutions Holding RGNX

# of Institutions

191

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $453M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Account